EXOZYMES INC. Earnings Per Share (Basic)
EXOZYMES INC. (EXOZ) reported Earnings Per Share (Basic) of -$0.33 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- EXOZYMES INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.33.
- EXOZYMES INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.28.
- EXOZYMES INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.32.
- EXOZYMES INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.27.
- EXOZYMES INC. earnings per share, basic for fiscal 2025 was -$1.09.
- EXOZYMES INC. earnings per share, basic for fiscal 2024 was -$0.89.
- EXOZYMES INC. earnings per share, basic for fiscal 2023 was -$0.33.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.33 10-Q · filed 2026-08-13 | -$0.61 10-Q · filed 2026-08-13 | -$0.93 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$1.20 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2026-03-31 | -$0.28 10-Q · filed 2026-05-14 | -$0.60 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.87 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$1.15 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-12-31 | -$0.32 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$0.59 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$0.87 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$1.09 10-K · filed 2026-03-30 |
| 2025-09-30 | -$0.27 10-Q · filed 2025-11-13 | -$0.55 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.78 10-Q · filed 2025-11-13 | -$1.02 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-06-30 | -$0.28 10-Q · filed 2026-08-13 | -$0.50 10-Q · filed 2026-08-13 | -$0.75 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$1.01 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-03-31 | -$0.22 10-Q · filed 2026-05-14 | -$0.47 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.73 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.95 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2024-12-31 | -$0.24 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$0.51 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$0.73 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$0.89 10-K · filed 2026-03-30 |
| 2024-09-30 | -$0.27 10-Q · filed 2025-11-13 | -$0.48 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$0.64 10-Q · filed 2025-11-13 | -$0.82 derived: net income ÷ weighted average shares · filed 2025-11-13 |
| 2024-06-30 | -$0.22 10-Q · filed 2025-08-12 | -$0.38 10-Q · filed 2025-08-12 | -$0.55 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$0.64 derived: net income ÷ weighted average shares · filed 2025-11-13 |
| 2024-03-31 | -$0.16 10-Q · filed 2025-05-12 | -$0.34 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$0.42 derived: net income ÷ weighted average shares · filed 2025-11-13 | |
| 2023-12-31 | -$0.18 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$0.26 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$0.33 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$0.08 10-Q · filed 2024-11-12 | -$0.15 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |